DOP008: Human intestinal V#CHR:delta_LOWER#2+ T-cells acquire antigen-presenting potency upon exposure to microbial phosphoantigen: modulation by mucosal inflammation and vedolizumab therapy

DOP008: Plexitis as a predictive factor for early post-operative endoscopic recurrence in patients with Crohn’s Disease undergoing a right hemicolectomy with ileocolonic anastomosis: Results from a prospective, single centre trial

DOP009: An autoimmunity-associated variant in PTPN22 protects from disease onset in mouse models of colitis

DOP009: Development of a simplified histological Geboes Score for Ulcerative Colitis

DOP010: Frequency and Characteristics of Infusion Reactions during Biosimilar Infliximab Treatment in Inflammatory Bowel Diseases: results from Central European nationwide cohort

DOP010: Incidence of inflammatory bowel diseases in the Faroe Islands from 1960-2014: a 54-year overview from a population-based cohort

DOP011: Early immunomodulator exposure and the long-term outcome of Crohn’s disease: target for changing the natural history?

DOP011: The ongoing rapid and significant rise of incident paediatric-onset inflammatory bowel disease in Scotland

DOP012: Incidence and risk factors of cutaneous manifestations in paediatric-onset Crohn’s Disease: A population-based study

DOP012: Do ulcerative colitis patients treated withcorticosteroids at diagnosis really have a more aggressive disease course?

DOP013: A 104 week mucosal healing assessment of symptomatic small bowel Crohn’s disease

DOP013: Increase of Inflammatory Bowel Disease incidence in teenagers in a prospective population-based-study over a 21-year period (1988-2008)

DOP014: Dietary patterns and risk of Inflammatory Bowel Disease in Europe: Results from the EPIC study

DOP014: Nutritional optimisation of pre-surgical Crohn’s disease patients with enteral nutrition significantly decreases length of stay and need for a stoma

DOP015: Myenteric plexitis is a risk factor for endoscopic and clinical postoperative recurrence after ileocolonic resection in Crohn’s disease

DOP016: Are extraintestinal manifestations associated with disease outcomes in Crohns Disease? Results from a population based inception cohort between 1977-2012

DOP016: Postoperative clinical recurrence is not different in Crohn’s disease patients classified as i2 on the Rutgeerts score with lesions confined to the ileocolonic anastomosis than in those with lesions of the neo-terminal ileum

DOP017: Colectomy Free Survival is Independent of Initial Infliximab Dosing Strategy in Hospitalised Ulcerative Colitis Patients

DOP017: Disease behaviour in Crohn's disease patients diagnosed in the biological era - A Dutch population-based IBD-SL cohort study

DOP018: A 17-year prospective cohort study of paediatric inflammatory bowel disease patients diagnosed less than 10 years of age (Paris A1a)